Biometic develops & manufactures bioactive scaffold systems for tissue engineering and bioreactor culture. These are optimized for a range of soft and hard tissue applications. As part of an ongoing collaborative and interdisciplinary development program, Biometic is helping advance fundamental understanding in tissue culture, biomechanics and medical research.
Commercializes a nano and micron sized ceramic spheres technology that provides encapsulation and controlled release of active molecules for a variety of applications including drug delivery, cosmeceuticals and speciality chemicals.
Living Cell is developing cell-based products to treat life threatening human diseases. The company has developed proprietary nanobiocapsules which allow encapsulated pig insulin producing cells, DiabeCell, to be implanted without the use of toxic immune suppressive drugs.